783. PavanM| Link| Bookmark|
December 16, 2016 8:35:31 AM
IPO Mentor (500+ Posts, 400+ Likes)
Baxter International Inc. (BAX) said that it agreed to acquire Claris Injectables Limited, a wholly owned subsidiary of Claris Lifesciences Limited, for total consideration of about $625 million.
I think one cannot expect more listing gains in this scrip.
as far as sheela is concerned the listing day upper circuit is bacause short bears entered the stock and could not short cover their position as per my idea. now you see the price is stays there only.
is it a long term story it depends the company''s future performance.
why i did not get any shares. I applied for 13 lots I should at least get one. This is silly. I heard everyone should get atleast one share although it depends
As other''s say 13 is unlucky no.So, not next time you apply 13+ or- 1.Good luck for 2017
777.3. sugreev| Link| Bookmark|
December 16, 2016 8:31:11 AM
(200+ Posts, 200+ Likes)
why did you apply 13 lots in one application? The allotment rules have changed. It is same as one lot in one application if the issue is over subscribed. You should have opened dmat account for all family members and applied one lot each by each of them.Then you might have got about half the shares applied for.
its a High Growth Pharma Company , main Business Research & Development so dont compare with Traditional Manufacturing Companies without any innovation They have 4-5 times Scientist than by which companies you compare so it will likely to attract MNC PE